References
- Zochodne DW. Diabetes and the plasticity of sensory neurons. Neurosci Lett. 2015;596:60–65. doi:10.1016/j.neulet.2014.11.017.
- Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA. 2015;314:2172–2181. doi:10.1001/jama.2015.13611.
- Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol. 2010;6:657–666. doi:10.1038/nrneurol.2010.160.
- Jones RCW 3rd, Lawson E, Backonja M. Managing neuropathic pain. Med Clin North Am. 2016;100:151–167. doi:10.1016/j.mcna.2015.08.009.
- Johnson MI, Bjordal JM. Transcutaneous electrical nerve stimulation for the management of painful conditions: focus on neuropathic pain. Expert Rev Neurother. 2011;11:735–753. doi:10.1586/ern.11.48.
- Mehndiratta MM, Hughes RA, Pritchard J. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;8:CD003906. doi:10.1002/14651858.CD003906.pub4.
- Cramer SC, Sur M, Dobkin BH, et al. Harnessing neuroplasticity for clinical applications. Brain. 2011;134:1591–1609. doi:10.1093/brain/awr039.
- Nijs J, Meeus M, Versijpt J, et al. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets. 2015;19:565–576. doi:10.1517/14728222.2014.994506.
- Tsuda M. Microglia in the spinal cord and neuropathic pain. J Diabetes Investig. 2016;7:17–26. doi:10.1111/jdi.12379.
- Garcia-Junco-Clemente P, Golshani P. PTEN: A master regulator of neuronal structure, function, and plasticity. Commun Integr Biol. 2014;7:e28358. doi:10.4161/cib.28358.
- Prockop DJ, Kota DJ, Bazhanov N, et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med. 2010;14:2190–2199. doi:10.1111/j.1582-4934.2010.01151.x.
- Crigler L, Robey RC, Asawachaicharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 2006;198:54–64.
- Zanier ER, Pischiutta F, Riganti L, et al. Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma. Neurotherapeutics. 2014;11:679–695. doi:10.1007/s13311-014-0277-y.
- Boido M, Piras A, Valsecchi V, et al. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. Cytotherapy. 2014;16:1059–1072. doi:10.1016/j.jcyt.2014.02.003.
- Scuteri A, Cassetti A, Tredici G. Adult mesenchymal stem cells rescue dorsal root ganglia neurons from dying. Brain Res. 2006;1116:75–81.
- Scuteri A, Donzelli E, Ravasi M, et al. Adult mesenchymal stem cells support cisplatin-treated dorsal root ganglion survival. Neurosci Lett. 2008;445:68–72. doi:10.1016/j.neulet.2008.08.056.
- De Becker A, Riet IV. Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy? World J Stem Cells. 2016;8:73–87. doi:10.4252/wjsc.v8.i3.73.
- Tian L, Prabhakaran MP, Ramakrishna S. Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules. Regen Biomater. 2015;2:31–45. doi:10.1093/rb/rbu017.
- Yu H, Fischer G, Ebert AD, et al. Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results. Mol Pain. 2015;11:5. doi:10.1186/s12990-015-0002-9.
- Petersen-Felix S, Curatolo M. Neuroplasticity–an important factor in acute and chronic pain. Swiss Med Wkly. 2002;132:273–278.